These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 24167081)
1. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment. Lizarraga KJ; Allen-Auerbach M; Czernin J; DeSalles AA; Yong WH; Phelps ME; Chen W J Nucl Med; 2014 Jan; 55(1):30-6. PubMed ID: 24167081 [TBL] [Abstract][Full Text] [Related]
2. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. Terakawa Y; Tsuyuguchi N; Iwai Y; Yamanaka K; Higashiyama S; Takami T; Ohata K J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375 [TBL] [Abstract][Full Text] [Related]
4. Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study. Karunanithi S; Sharma P; Kumar A; Gupta DK; Khangembam BC; Ballal S; Kumar R; Kumar R; Bal C Eur J Radiol; 2014 Jan; 83(1):219-25. PubMed ID: 24191944 [TBL] [Abstract][Full Text] [Related]
5. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166 [TBL] [Abstract][Full Text] [Related]
6. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience. Ledezma CJ; Chen W; Sai V; Freitas B; Cloughesy T; Czernin J; Pope W Eur J Radiol; 2009 Aug; 71(2):242-8. PubMed ID: 18511228 [TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas. Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821 [TBL] [Abstract][Full Text] [Related]
8. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas. Imani F; Agopian VG; Auerbach MS; Walter MA; Imani F; Benz MR; Dumont RA; Lai CK; Czernin JG; Yeh MW J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420 [TBL] [Abstract][Full Text] [Related]
9. Identify glioma recurrence and treatment effects with triple-tracer PET/CT. Li C; Yi C; Chen Y; Xi S; Guo C; Yang Q; Wang J; Sai K; Zhang J; Ke C; Chen F; Lv Y; Zhang X; Chen Z BMC Med Imaging; 2021 May; 21(1):92. PubMed ID: 34059015 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery. Cicone F; Minniti G; Romano A; Papa A; Scaringi C; Tavanti F; Bozzao A; Maurizi Enrici R; Scopinaro F Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):103-11. PubMed ID: 25182751 [TBL] [Abstract][Full Text] [Related]
11. ¹⁸F-fluorodopa positron-emission tomography: an emerging imaging modality for patients with brain metastases. Lizarraga KJ; De Salles AA; Chen W Expert Rev Med Devices; 2014 Jul; 11(4):327-9. PubMed ID: 24894391 [TBL] [Abstract][Full Text] [Related]
12. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis. Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742 [TBL] [Abstract][Full Text] [Related]
13. Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients. Herrmann K; Czernin J; Cloughesy T; Lai A; Pomykala KL; Benz MR; Buck AK; Phelps ME; Chen W Neuro Oncol; 2014 Apr; 16(4):603-9. PubMed ID: 24305722 [TBL] [Abstract][Full Text] [Related]